Case Reports in Critical Care / 2019 / Article / Tab 1

Case Report

Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum

Table 1

Laboratory data upon hospital admission.

Hematology
WBC17880/μL
RBC3.54 million/μL
Hb11.5 g/dL
Hct32.9%
Plt24000/μL

Coagulation tests
PT19%
PT-INR1.52
APTT43.9 s
D-dimer1.9 μg/mL
AT358%

Biochemistry
AST66 U/L
ALT46 U/L
LDH472 U/L
γ-GTP36 U/L
T-BIL4 mg/dL
D-BIL3.1 mg/dL
CK107 U/L
TP5.1 g/dL
Alb2 g/dL
BUN85.1 mg/dL
Cre2.76 mg/dL
Na128 mEq/L
K3.7 mEq/L
Cl89 mEq/L

Serology
CRP25.75 mg/dL
Presepsin3551 pg/mL
Procalcitonin77.21 ng/mL
Endotoxin29.1 pg/mL
β-D glucan≦5.0 pg/mL
HbA1C5.8%
Glu121 mg/dL
HBs-Ag(−)
HCV-Ab(−)
HIV(−)

Arterial blood gases
(10 L reservoir oxygen)
pH7.509
pCO226.9 mmHg
pO273.9 mmHg
20.5 mEq/L
BE−0.2 mEq/L
Lac3.4 mmol/L

Urinalysis
Pneumococcal-Ag(−)
Legionella-Ag(−)

Influenza
Type A(−)
Type B(−)

Acid-fast
Smear(−)
Culture(−)

Culture
Sputum and blood
Fusobacterium necrophorum

MIC of F. necrophorum

AntibioticsMIC

Ampicillin0.12S
Penicillin G0.06S
Sulbactam/ampicillin≦0.06S
Cefmetazole≦1S
Meropenem≦0.25S
Levofloxacin≦2S
Clindamycin≦0.12S
Tazobactam/piperacillin≦16S

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.